Avatar feed
Responses: 2
CSM Chuck Stafford
4
4
0
Good to know -- thanks for posting
(4)
Comment
(0)
Avatar small
SSG Robert Webster
1
1
0
And what are these news reports leaving out?

"Further study is required to understand the following: Safety and efficacy beyond 2 months and in groups not included in this trial (e.g., children, pregnant women, and immunocompromised persons).

Two doses of an mRNA-based vaccine were safe over a median of two months and provided 95% protection against symptomatic Covid-19 in person 16 years of age or older."
https://www.nejm.org/doi/full/10.1056/NEJMoa2034577
(1)
Comment
(0)
Avatar small

Join nearly 2 million former and current members of the US military, just like you.

close